Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG

/R E P E A T -- Notice to the media - Government of Canada and the Government of the Northwest Territories to announce bilateral agreement/


YELLOWKNIFE, Feb. 20, 2018 /CNW/ - Michael McLeod, Member of Parliament for the Northwest Territories, on behalf of the Honourable Ginette Petitpas Taylor, federal Minister of Health, and the Honourable Glen Abernethy, Minister of Health and Social Services, will be available for a photo opportunity as they announce a bilateral agreement between the Government of Canada and the Government of the Northwest Territories.

Date
February 21, 2018

Time
12:00 pm (MST)

Location
Media Room Legislative Assembly
4570-48 Street
Yellowknife, NT X1A 3A5

 

SOURCE Health Canada


These press releases may also interest you

at 10:19
Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits...

at 10:17
Fx Chocolate®, a Designs for Health brand that provides functional amounts of high-quality supplements in handcrafted chocolate, today announced the launch of its Yes Whey!!!tm chocolate supplement bar. Yes Whey!!!tm harnesses 15 grams of...

at 10:16
Varian, a Siemens Healthineers Company, announces its collaboration with BaraSeen Medical Company to introduce the first Halcyon system in Saudi Arabia - with its hallmark sustainability features - at BaraSeen's initial specialized standalone Batik-X...

at 10:15
From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that...

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....



News published on and distributed by: